Coronary disease & ACS

Diagnostic and prognostic impact of new pathophysiology-based categorization of type 1 and type 2 myocardial infarction: data from the French RICO survey

Am Heart JPublished Retrospective cohort study

Authors' conclusion

Our large observational multicenter study shows major disparities in mortality according to type of MI and support the relevance of the new MI classification to improve risk classification, taking into account CAD in T2MI.

Study context

Population
Consecutive patients hospitalised for acute myocardial infarction (MI) in a French multicentre database (RICO)
Participants
4,573 patients
Exposure
T1MI vs T2AMI vs T2BMI under new pathophysiology-based classification
Outcome
Classification of MI type
Methodological detailsmulticentre, consecutive patients
  • Multicentre
  • Consecutive patients

Main finding

As reported in the abstract

Initially diagnosed T1MI
3,710 (81.1%)
Initially diagnosed T2MI
863 (18.9%)
T2MI reclassified as T1MI
96
Remaining T2MI
767
T2MI undergoing coronary angiography
567
T2AMI among angiographed T2MI
68.6%
T2BMI among angiographed T2MI
31.4%

Observational data: associations, not effects.

Further findings

In-hospital outcomes (severe HF, AF or flutter)

Severe HF worse in T2AMI vs T1MI and T2BMI
P < 0.001
AF or flutter worse in T2AMI vs T1MI and T2BMI
P < 0.001

All-cause and CV mortality · 1 year

Higher all-cause and CV mortality in T2AMI vs T1MI and T2BMI (Kaplan-Meier)
P < 0.001
Type of MI independent predictor of death (multivariate Cox regression)

Safety

Severe bleeding · in-hospital

Severe bleeding worse in T2AMI vs T1MI and T2BMI
P < 0.001

Original publication

Diagnostic and prognostic impact of new pathophysiology-based categorization of type 1 and type 2 myocardial infarction: data from the French RICO survey. Am Heart J. Published 11 September 2023. doi:10.1016/j.ahj.2023.09.001

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.